STEPHANIE CARLINO: Open Payments
NPI 1831322056 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,429 in 59 payments from 14 companies in 2025. Trend: 2023 $2,144 · 2024 $1,812 · 2025 $2,429
Food & beverage: $1,289Consulting: $1,140
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $1,265 |
| Novartis Pharmaceuticals Corporation | 9 | $231 |
| ABBVIE INC. | 10 | $187 |
| Incyte Corporation | 5 | $119 |
| Janssen Biotech, Inc. | 4 | $109 |
| PFIZER INC. | 4 | $89 |
| Organon LLC | 4 | $82 |
| Amgen Inc. | 4 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $70 |
| LEO Pharma Inc. | 3 | $65 |
Products named: Bimzelx, COSENTYX, SKYRIZI, OPZELURA, TREMFYA, CIBINQO, OTEZLA, ILUMYA.
Industry payments across DE — which companies pay providers there.
